Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
CMV-specific cellular therapy for acute myeloid leukemia?
Thomson KJ, Mackinnon S, Peggs KS.
Blood. 2012 Jan 26;119(4):1088-90; author reply 1090-1. No abstract available.
Related citations
Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.
Steininger C, Widhopf GF 2nd, Ghia EM, Morello CS, Vanura K, Sanders R, Spector D, Guiney D, Jäger U, Kipps TJ.
Blood. 2012 Mar 8;119(10):2293-301. Epub 2012 Jan 10.
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).
Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P, Moreau JF, Déchanet-Merville J.
Blood. 2012 Feb 9;119(6):1418-27. Epub 2011 Dec 16.
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X, Lopez-Vergès S, Lanier LL, Weisdorf D, Miller JS.
Blood. 2012 Mar 15;119(11):2665-74. Epub 2011 Dec 16.
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
Della Chiesa M, Falco M, Podestà M, Locatelli F, Moretta L, Frassoni F, Moretta A.
Blood. 2012 Jan 12;119(2):399-410. Epub 2011 Nov 17.
Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells.
Carlier J, Martin H, Mariamé B, Rauwel B, Mengelle C, Weclawiak H, Coaquette A, Vauchy C, Rohrlich P, Kamar N, Rostaing L, Herbein G, Davrinche C.
Blood. 2011 Dec 22;118(26):6783-92. Epub 2011 Oct 26.
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M.
Blood. 2011 Sep 22;118(12):3301-10. Epub 2011 Aug 5.
Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients.
Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C.
Blood. 2011 Nov 17;118(20):5689-96. Epub 2011 Sep 21.
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation.
Vairo D, Tassone L, Tabellini G, Tamassia N, Gasperini S, Bazzoni F, Plebani A, Porta F, Notarangelo LD, Parolini S, Giliani S, Badolato R.
Blood. 2011 Aug 18;118(7):1806-17. Epub 2011 Jul 19.
CMV: when bad viruses turn good.
Barrett AJ.
Blood. 2011 Aug 4;118(5):1193-4. No abstract available.
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.
Khanna N, Stuehler C, Conrad B, Lurati S, Krappmann S, Einsele H, Berges C, Topp MS.
Blood. 2011 Jul 28;118(4):1121-31. Epub 2011 Jun 3.
Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.
Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier LL, Anderson SK, Redelman D, Murphy WJ.
Blood. 2011 Jun 30;117(26):7032-41. Epub 2011 Apr 15.
Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis.
Akpek G, Mikulski M, Kleinberg M, Badros A, Yanovich S, Rapoport AP.
Blood. 2011 May 26;117(21):5772-4. No abstract available.
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.
Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW.
Blood. 2011 Aug 4;118(5):1402-12. Epub 2011 May 3.
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.
Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell S, Corey L, Greenberg PD.
Blood. 2011 May 19;117(20):5391-402. Epub 2011 Mar 21.
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.
Yamamoto T, Price DA, Casazza JP, Ferrari G, Nason M, Chattopadhyay PK, Roederer M, Gostick E, Katsikis PD, Douek DC, Haubrich R, Petrovas C, Koup RA.
Blood. 2011 May 5;117(18):4805-15. Epub 2011 Mar 11.
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.
Sørensen RB, Hadrup SR, Svane IM, Hjortsø MC, Thor Straten P, Andersen MH.
Blood. 2011 Feb 17;117(7):2200-10. Epub 2010 Nov 15.
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.
Wang X, Berger C, Wong CW, Forman SJ, Riddell SR, Jensen MC.
Blood. 2011 Feb 10;117(6):1888-98. Epub 2010 Dec 1.
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.
Blood. 2011 Jan 20;117(3):848-56. Epub 2010 Oct 28.
The silent war against CMV in CLL.
Akbar AN.
Blood. 2010 Oct 21;116(16):2869-70. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on